genomic differences in smm progressors versus non-progressors
Published 3 years ago • 38 plays • Length 3:02Download video MP4
Download video MP3
Similar videos
-
0:49
genomic differences between smoldering and multiple myeloma
-
3:23
molecular characteristics associated with increased risk of disease progression in smm
-
0:55
important genomic factors for sm progression
-
1:12
understanding genetic and non-genetic mechanisms involve in aml disease progression
-
1:49
genomic advancements in non-malignant hematology
-
3:43
genomic profiling to predict prognosis for patients with hr-smm
-
3:28
molecular prognostication in smm
-
31:08
a new frontier in biomarker discovery - october 4, 2022
-
5:00
long-term results of the phase ii revive study evaluating rusfertide in patients with pv
-
50:56
chip and ccus, precursors to mds
-
1:44
the genomics of rt and prognostic implications of rt characterization
-
1:38
the genomic definition of high-risk myeloma
-
1:30
the genomic definition of ultra-high-risk multiple myeloma
-
1:19
the importance of genomic testing in mpns
-
0:52
genomic profiling at diagnosis of myeloid neoplasms
-
3:01
challenges in distinguishing between pre-mds states and mds, and approaches to improve diagnosis
-
1:51
novel insights into genomic classification and prognosis in aml
-
4:01
the latest genomic updates in the field of mds
-
2:05
what role could genomics play in oncology?
-
1:00
how genomic testing has influenced treatment approaches and clinical trial design in mpns
-
1:46
ctc whole-genome sequencing vs fish to monitor the emergence of multiple myeloma high-risk subclones